GenMark Diagnostics to Present at Bank of America Merrill Lynch 2015 Health Care Conference

GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference to be held at the Encore Hotel in Las Vegas, NV on Wednesday, May 13, 2015 at 3:00 pm Pacific Time. The presentation will be made available at http://ir.genmarkdx.com.

ABOUT GENMARK DIAGNOSTICS

GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark’s proprietary eSensor^® detection technology, GenMark’s eSensor XT-8^TM system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. The eSensor detection technology is also incorporated into GenMark’s sample-to-answer system, ePlex^TM. For more information, visit www.genmarkdx.com.